The USTR has raised alarms over India's price caps on coronary stents and high customs duties on drug formulations, arguing ...

A team from the University of Birmingham have conducted a five-year trial, with almost 500 participants, assessing different methods of restoring blood flow for patients suffering severe ischaemia ...

Drug-eluting stents (DES) are used to treat heart artery blockages. Under the updated price structure notified by the state ...

The Gujarat government has stated that the move aims to ensure "cost-effectiveness while ensuring high-quality patient care" ...

Currently, all drug-eluting stents (DES), used to treat blocked heart arteries, are priced at Rs 35,000. The Indian Express ...

The order says stents approved by the United States Food and Drug Adminis-tration will be priced at Rs 25,000 per stent, and ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

Severely calcified coronary artery lesions are encountered increasingly frequently in clinical practice. The technical challenges faced by the interventional cardiologist in the treatment of these ...